Which GLP-1 Telehealth Companies Are Best? See Top Picks From US News & World Report
- U.S. News & World Report released its first-ever ratings for telehealth platforms offering GLP-1 medications on August 12.
- About 11% of Americans are currently using GLP-1 drugs for weight loss, with 17% obtaining prescriptions through online providers.
- The ratings evaluated 20 telehealth companies based on metrics such as clinical support, transparency, and customer satisfaction.
- The top-rated companies included Amazon One Medical and Found, with ratings ranging from 3.9 to 4.9 on a five-point scale.
- Experts caution that some telehealth platforms may lack adequate clinical oversight and support.
Individuals seeking to lose weight with GLP-1 medications can choose from a growing number of telehealth companies that provide these drugs online. U.S. News & World Report has introduced its first ratings for the best telehealth platforms for GLP-1s, aiming to assist consumers in making informed decisions.
As of now, approximately 11% of Americans are using GLP-1 drugs for weight loss, marking a new high. While most patients still obtain these medications through traditional healthcare providers, a significant portion is turning to online services.
The ratings focused on 20 companies that offer FDA-approved GLP-1 drugs and assessed them based on six key metrics. The top-rated companies received high marks for patient safety and clinical support, indicating a commitment to quality care in this rapidly evolving sector.
哪些GLP-1远程医疗公司是最佳选择？来自《美国新闻与世界报道》的顶级推荐
希望通过GLP-1药物减肥的个人可以选择越来越多的提供在线药物的远程医疗公司。《美国新闻与世界报道》推出了首个针对GLP-1远程医疗平台的评级，旨在帮助消费者做出明智的选择。
目前，约11%的美国人正在使用GLP-1药物减肥，创下新高。尽管大多数患者仍通过传统医疗提供者获得这些药物，但越来越多的人开始转向在线服务。
评级集中在20家公司，这些公司提供FDA批准的GLP-1药物，并根据六个关键指标进行评估。排名最高的公司在患者安全和临床支持方面获得了高分，表明在这一快速发展的领域中对优质护理的承诺。